Seeking Alpha

Arena Pharmaceuticals (ARNA) gains 14% premarket after rival Orexigen (OREX) looks set to gain...

Arena Pharmaceuticals (ARNA) gains 14% premarket after rival Orexigen (OREX) looks set to gain clearance to introduce the first new obesity medicine in the U.S. over the last ten years. The company had its own experimental diet drug rejected last October on safety worries.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs